News for Healthier Living

GLP-1 Treatment Linked to Lower Risk of Hospitalization and Death in Older Adults with Fatty Liver Disease

A new Houston Methodist Research Institute study finds that older adults with metabolic dysfunction-associated steatotic liver disease (MASLD) who received GLP-1-based treatment experienced significantly lower risks of liver disease-related complications, hospitalization and death, compared with similar patients who did not receive the treatment.

October 13, 2026


October 13 2026

October 12 2026

October 11 2026

October 10 2026

October 9 2026

October 8 2026

October 7 2026

October 6 2026

October 5 2026

October 2 2026

October 1 2026

September 30 2026

September 29 2026